The clinical examination of the diabetic foot in daily practise

Diabetic Medicine

Volumn 13, Issue SUPPL. 1, 1996, Pages

  De Heus Van Putten, M A ^a   Schaper, N C ^b   Bakker, K ^c  

^a Hogeschool Eindhoven   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Infection and Immunology   (Netherlands)

Author keywords

clinical examination; diabetic foot; podiatry; prevention

Indexed keywords

CLINICAL EXAMINATION; CONFERENCE PAPER; DIABETIC FOOT; HUMAN; NEUROLOGIC EXAMINATION; PODIATRY; RISK ASSESSMENT;

EID: 0030038927     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/dme.1996.13.s1.55     Document Type: Conference Paper

References (17)

1. Boulton AJM. The pathogenesis of diabetic foot problems: an overview. Diabetic Med 1996; 13 (Suppl 1): 12-16.
2. LoGerfo FW, Coffman JD. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984; 25: 1615-1619.
3. Takolander R, Rauwerda JA. The use of non-invasive vascular assessment in diabetic patients with foot lesions. Diabetic Med 1996; 13 (Suppl 1): 39-42.
4. Ziegler D. Diagnosis and management of diabetic peripheral neuropathy. Diabetic Med 1996; 13 (Suppl 1): 34-38.
5. Reiber GE. The epidemiology of diabetic foot problems. Diabetic Med 1996; 13 (Suppl 1): 6-11.
6. Maser RE, Nielsen VK, Bass EB, Manjoo Q, Dorman SJ, Kelsey SF. Measuring diabetic neuropathy: assessment and comparison of clinical and quantative sensory testing. Diabetes Care 1989; 12: 270-275.
7. Young MJ, Boulton AJM, MacLeod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154.
8. Wiles PG, Pearce SM, Rice PJS, Mitchell JMO. Vibration perception threshold: influence of age, height, sex and smoking and calculation of accurate centile values. Diabetic Med 1991, 8: 157-161.
9. Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diabetes Care 1994; 17: 557-560.
10. Bloom S, Till S, Sonksen P, Smith S. Use of a Biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects. Br Med J 1984; 288: 1793-1795.
11. Sosenko JM, Kato M, Soto R, Bild DE. Comparison of quantative sensory-threshold measures for their association with foot ulceration in diabetic patients. Diab Care 1990; 13: 1057-1061.
12. McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, Pecoraro RE. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. Diab Care 1995, 18: 216-219.
13. Kumar S, Fernando DJS, Veves A, Knowles EA, Young MJ, Boulton AJM. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 1991; 13: 63-68.
14. Rith-Najarian SJ, Stolusky Th, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. Diab Care 1992; 15: 1386-1389.
15. Cavanagh PR, Ulbrecht JS, Caputo GM. Biomechanical aspects of diabetic foot disease: aetiology, treatment and prevention. Diabetic Med 1996; 13 (Suppl 1): 17-22.
16. Fernando DJS, Masson EA, Veves A, Boulton AJM. Relationship of Limited Joint Mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 1991; 14: 8-11.
17. Sims DS, Cavanagh PR, Ulbrecht JS. Risk factors in the diabetic foot: Recognition and management. Physical Therapy 1988; 68: 1887-1902.